Al's Comment:

 This gives another option for recurrent brain tumor treatment. They did not say what the results have been.  An FDA 510 K clearance is not a high hurdle - the treatment just needs to be as safe and effective as a similiar treatment that is already being marketed.  

---

Posted on: 07/09/2018

IsoRay Announces FDA Clearance of GammaTile™ Therapy for the Treatment of Recurrent Brain Neoplasms

https://globenewswire.com/news-release/2018/07/09/1534873/0/en/IsoRay-Announces-FDA-Clearance-of-GammaTile-Therapy-for-the-Treatment-of-Recurrent-Brain-Neoplasms.html

 

---

Click HERE to return to brain tumor news headlines.